GANX

Gain Therapeutics, Inc. Common Stock (GANX) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.

GANX has 2 Form 4 insider filings recorded at the SEC in the past 30 days^[1].